A Combination Therapy Strategy to Prevent Anti-PD-1 Therapy Resistance in Metastatic Ovarian Cancer Patients
Georgetown University
Georgetown University
Peking University Third Hospital
WestVac Biopharma Co., Ltd.
On Target Laboratories, LLC
Helios University Hospital Wuppertal
Qilu Pharmaceutical Co., Ltd.
The First Affiliated Hospital of Soochow University
Convalife (Shanghai) Co., Ltd.
Cancer Research UK
Kaiser Permanente
Ellele Health
University of Chicago
Zhejiang University